A new study suggests that more women are being prescribed beta-3 agonists over anticholinergics for the treatment of overactive bladder (OAB), suggesting that more clinicians may be choosing this ...
Certain bottles of the bladder medication mirabegron have been recalled nationwide.The recalled pills contain ...
Before you start treatment with Myrbetriq, tell your doctor and pharmacist which prescription, over-the-counter, and other medications you take. By sharing this information with them, you may help ...
Active ingredient: Fesoterodine fumarate 4 mg, 8 mg; extended-release tablets. Indication: Overactive bladder (OAB) with urge urinary incontinence, urgency, and frequency. Pharmacology: Fesoterodine ...
A recent study found that women with overactive bladder who received antimuscarinics were 38% more likely to be diagnosed with depressive disorder within the next 3 years than those who did not ...
EatingWell on MSN
The FDA issued a recall on bladder medication nationwide
Check your medication ASAP.
Austin, June 04, 2025 (GLOBE NEWSWIRE) -- Overactive Bladder Treatment Market Size & Growth Analysis: According to SNS Insider, the Overactive Bladder Treatment Market size was estimated at USD 3.63 ...
(Reuters) - Watson Pharmaceuticals Inc said it signed a deal to market Antares Pharma Inc's experimental treatment for overactive bladder in the United States and Canada. According to the terms of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results